Transfected aptamers in HUVECs decrease tube formation. by Yolanda M. Fortenberry (248282)

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Gap junctions decrease theta range oscillation. by Wei-Pang Chang (587554)

“…<p>(A) The frequency analysis showed that the frequency of seizure-like activity predominantly occurred in the delta (1.5–4 Hz) and theta (4–8) ranges. …”

Global decrease of OTRs leads to vessel rarefaction. by Dan Hu (144171)

The substitution F447L is adaptive for J4_S52-HVR1, while it decreases infectivity of parental J4 and J4_ΔHVR1 HCVcc. by Christina Holmboe Olesen (11154333)

Decreased Fas-induced apoptosis in hTERT⁺ vs. hTERT^ctrl transfected MLE cells. by Nissim Arish (736264)

“…<p>MLE cells were transfected with hTERT or control expression vector, and exposed to Fas or control IgG mAb (10 μg/ml, 24h). (A) Histogram plot and (B) confocal microscopy of Annexin V staining (blue) and PI (red) in hTERT⁺ vs. hTERT^ctrl cells showing decreased Annexin V staining in hTERT⁺ when compared to hTERT^ctrl transfected cells (MLE). …”

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

(A) Decreasing CaMKII activity by KN-93 (high-3 µmol/L, low-0.5 µmol/L), AIP (high-10 µmol/L, low-2 µmol/L), or decreasing calmodulin activity by W-7 (high-50 µmol/L, low-20 µmol/L) decreases spontaneous AP firing rate (n = 10 for each drug), cAMP (n = 4 for each drug) and ATP (n = 5 for each drug). by Yael Yaniv (162548)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

PKCδ inhibitor decreases sepsis-mediated activation of platelet PKCδ. by Elisabetta Liverani (430615)

<i>Syx5</i> suppression in <i>Drosophila</i> S2 cells decreases copper accumulation. by Melanie Norgate (234832)

Effects of Cu (5 µM) pretreatment on Hcy-induced decrease in cell viability and LDH release. by Daoyin Dong (424519)

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Hsp90 interacts with BMS1 and decreased Hsp90 function compromises 80S ribosome and polysome stability at 16°C. by Eric A. Franzosa (130063)

Atorvastatin decreases proliferation of breast cancer cells more potently than rosuvastatin. by Colin H. Beckwitt (2037196)

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

Purine nucleotides are decreased in long-term hypoxia. by Emily B. Cohen (9106088)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”

Virus replication is decreased by treatment of HDAC inhibitors. by Angelika Danielsson (229695)

“…<p>LNCaP and PC-346C were transduced with Ad[i/PPT-E1A, E3] and Ad5 wt and BON cells were transduced with Ad[CgA-E1A] and Ad5 wt. …”

L-sel decreases the number of circulating lymphocytes. by Izabela Rozenberg (214521)

“…<p><i>ApoE</i>^{−<i>/</i>−}<i>L-sel</i>^{−<i>/</i>−} animals exhibit increased number of <b>A</b>) total blood lymphocytes (n = 5–8; ^*p<0.05), <b>B</b>) T-cytotoxic cells (CD8⁺; n = 6–7; ^**p<0.01, ^#p<0.05), <b>C</b>) B lymphocytes (CD19⁺; n = 5–7; ^*p<0.05, ^#p<0.05), <b>D</b>) total T-helper cells (CD4⁺; n = 6–7; ^#p<0.0), <b>E</b>) naive T-helper cells (CD4⁺CD44⁻; n = 5–7; ^*p<0.05; ^##p<0.0001) after 6 and 12 weeks of HCD, respectively. …”